Episurf Medical cuts consideration share price in Kuststaden Invest acquisition to SEK 0.075

• Episurf Medical cut the consideration share price for its Kuststaden Invest acquisition to SEK 0.075 per B share from SEK 0.10.
• The revised terms increase consideration shares to 2,450,373,333 B shares, raising potential dilution to approximately 12.1% from 9.3%.
• The approximately SEK 254 million purchase price now includes SEK 70 million in seller promissory notes instead of cash.
• Kuststaden's agreed property value remains SEK 647 million; closing is expected November 18, 2026.
• A five-year SEK 876 million loan will finance the Kuststaden acquisition and the Botrygg property portfolio purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20261111:BIT:8087:0) on November 11, 2026, and is solely responsible for the information contained therein.